One of the key challenges in tissue engineering is ensuring that the implanted material is biocompatible and does not elicit an adverse immune response. Epibone addresses this by using biocompatible nanomaterials and biodegradable polymers that gradually dissolve as the new bone tissue forms. Additionally, by using the patient's own cells, the risk of rejection is significantly minimized, leading to better integration and healing outcomes.
